Table 2.
Tumor response.
Overall | RECIST 1.1 | p | mRECIST | p | ||
---|---|---|---|---|---|---|
LenHAP (n=108) | BevHAP (n=108) | LenHAP (n=108) | BevHAP (n=108) | |||
CR | 0 | 0 | 10 (9.3%) | 4 (3.7%) | 0.097 | |
PR | 67 (62.0%) | 53 (49.1%) | 0.055 | 80 (74.1%) | 70 (64.8%) | 0.14 |
SD | 35 (32.4%) | 43 (39.8%) | 0.26 | 12 (11.1%) | 22 (20.4%) | 0.062 |
PD | 6 (5.6%) | 11 (10.2%) | 0.21 | 6 (5.6%) | 11 (10.2%) | 0.21 |
NA | 0 | 1 (0.9%) | 1 | 0 | 1 (0.9%) | 1 |
ORR | 67 (62.0%) | 53 (49.1%) | 0.055 | 90 (83.3%) | 74 (68.5%) | 0.011 |
DCR | 102 (94.4%) | 96 (88.9%) | 0.14 | 102 (94.4%) | 96 (88.9%) | 0.14 |
Intrahepatic | RECIST 1.1 | p | mRECIST | p | ||
LenHAP (n=108) | BevHAP (n=108) | LenHAP (n=108) | BevHAP (n=108) | |||
CR | 0 | 0 | 24 (22.2%) | 11 (10.2%) | 0.016 | |
PR | 72 (66.7%) | 54 (50%) | 0.013 | 72 (66.7%) | 63 (58.3%) | 0.21 |
SD | 34 (31.5%) | 46 (42.6%) | 0.091 | 10 (9.3%) | 26 (25.9%) | 0.003 |
PD | 2 (1.9%) | 7 (6.5%) | 0.17 | 2 (1.9%) | 7 (6.5%) | 0.17 |
NA | 0 | 1 (0.9%) | 1 | 0 | 1 (0.9%) | 1 |
ORR | 72 (66.7%) | 54 (50%) | 0.013 | 96 (88.9%) | 74 (68.5%) | <0.001 |
DCR | 106 (98.1%) | 100 (92.6%) | 0.052 | 106 (98.1%) | 100 (92.6%) | 0.052 |